High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.

Item
http://www.wikidata.org/entity/Q33495772
Optimal primary surgical treatment for advanced epithelial ovarian cancerCurrent treatment for ovarian cancer.Treatment strategy for recurrent and refractory epithelial ovarian cancer: efficacy of high-dose chemotherapy with hematopoietic stem cell transplantationHigh-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study.First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidenceVariability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival.Trial-level analysis of progression-free survival and response rate as end points of trials of first-line chemotherapy in advanced ovarian cancer.High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma: long term results for 105 patients.Abandoning "TAP" as treatment of metastatic endometrial cancer: a serious example of the consequences resulting from the failure to adequately define the question being addressed in a phase 3 trial.A multicenter randomized Phase II trial of granulocyte-colony stimulating factor-supported, platinum-based chemotherapy with flexible midcycle cisplatin administration in patients with advanced ovarian carcinoma. PSAMOMA Cooperative Group, Spain.
P2860

High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest.

Item
http://www.wikidata.org/entity/Q33495772
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
name
High-dose versus low-dose cisp ...... Gruppo Oncologico Nord-Ovest.
@ast
High-dose versus low-dose cisp ...... Gruppo Oncologico Nord-Ovest.
@en
type
label
High-dose versus low-dose cisp ...... Gruppo Oncologico Nord-Ovest.
@ast
High-dose versus low-dose cisp ...... Gruppo Oncologico Nord-Ovest.
@en
prefLabel
High-dose versus low-dose cisp ...... Gruppo Oncologico Nord-Ovest.
@ast
High-dose versus low-dose cisp ...... Gruppo Oncologico Nord-Ovest.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
High-dose versus low-dose cisp ...... Gruppo Oncologico Nord-Ovest.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921